Huntington's disease drug maker UniQure to seek FDA approval for gene therapy
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure plans to seek FDA approval for its experimental…
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure plans to seek FDA approval for its experimental…
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…
Agriculture Secretary Brooke Rollins told CNBC on Monday that the New World screwworm is a “little pest.” In the past,…
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
Cattle wander through a field on June 6, 2026 in La Pryor, Texas. Joel Ángel Juárez | fake images The…
Nikolas Kokovlis | Nurfoto | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Nordisk and Eli Lilly They took their battle against the GLP-1 pill to the biggest meeting on obesity this weekend…
Shares in weight-loss drug maker Zealand Pharma plunged as much as 26% on Monday after new data on its experimental…
Cattle are grazed in a barn on June 5, 2026 in Dublin, Texas. Brandon Bell | fake images The United…
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop drugs faster and make smarter decisions throughout the research…